Platelet-Rich Plasma for Patients with Olfactory Dysfunction: Myth or Reality? A Systematic Review

Background: With promising outcomes, platelet-rich plasma (PRP) has recently been suggested as a treatment for olfactory dysfunction (OD). Methods: Clinical studies utilizing PRP in OD caused by COVID-19, trauma, anesthetic exposure, viral infection, and chronic rhinosinusitis were included in a sys...

Full description

Bibliographic Details
Main Authors: Antonio Moffa, Domiziana Nardelli, Lucrezia Giorgi, Simone Di Giovanni, Luca Carnuccio, Carmen Mangino, Peter Baptista, Michele Vacca, Manuele Casale
Format: Article
Language:English
Published: MDPI AG 2024-01-01
Series:Journal of Clinical Medicine
Subjects:
Online Access:https://www.mdpi.com/2077-0383/13/3/782
_version_ 1797318593872920576
author Antonio Moffa
Domiziana Nardelli
Lucrezia Giorgi
Simone Di Giovanni
Luca Carnuccio
Carmen Mangino
Peter Baptista
Michele Vacca
Manuele Casale
author_facet Antonio Moffa
Domiziana Nardelli
Lucrezia Giorgi
Simone Di Giovanni
Luca Carnuccio
Carmen Mangino
Peter Baptista
Michele Vacca
Manuele Casale
author_sort Antonio Moffa
collection DOAJ
description Background: With promising outcomes, platelet-rich plasma (PRP) has recently been suggested as a treatment for olfactory dysfunction (OD). Methods: Clinical studies utilizing PRP in OD caused by COVID-19, trauma, anesthetic exposure, viral infection, and chronic rhinosinusitis were included in a systematic review. Results: Ten clinical studies were qualitatively analyzed. Six of these studies used the PRP for OD caused by COVID-19, one on OD after functional endoscopic sinus surgery, and three on post-infectious or post-trauma OD. The population included 531 patients, ranging in age from 15 to 63. Conclusion: The use of PRP may be a risk-free and efficient therapeutic option with very encouraging outcomes. Indeed, it enhances olfactory perception in patients who not only exhibit COVID-19 infection aftereffects, but also in those who have lost their sense of smell due to trauma, rhinosinusitis, rhinitis, or even surgery. To evaluate the PRP’s therapeutic benefits in OD patients and to compare the efficacy of different therapeutic protocols with regard to treatment schedules, there is an urgent need for focused controlled trials.
first_indexed 2024-03-08T03:53:36Z
format Article
id doaj.art-546b9774ed814723b140691e3fdefe5c
institution Directory Open Access Journal
issn 2077-0383
language English
last_indexed 2024-03-08T03:53:36Z
publishDate 2024-01-01
publisher MDPI AG
record_format Article
series Journal of Clinical Medicine
spelling doaj.art-546b9774ed814723b140691e3fdefe5c2024-02-09T15:16:01ZengMDPI AGJournal of Clinical Medicine2077-03832024-01-0113378210.3390/jcm13030782Platelet-Rich Plasma for Patients with Olfactory Dysfunction: Myth or Reality? A Systematic ReviewAntonio Moffa0Domiziana Nardelli1Lucrezia Giorgi2Simone Di Giovanni3Luca Carnuccio4Carmen Mangino5Peter Baptista6Michele Vacca7Manuele Casale8Integrated Therapies in Otolaryngology, Fondazione Policlinico Università Campus Bio-Medico di Roma, 00128 Rome, ItalySchool of Medicine, Università Campus Bio-Medico di Roma, 00128 Rome, ItalyIntegrated Therapies in Otolaryngology, Fondazione Policlinico Università Campus Bio-Medico di Roma, 00128 Rome, ItalyIntegrated Therapies in Otolaryngology, Fondazione Policlinico Università Campus Bio-Medico di Roma, 00128 Rome, ItalySchool of Medicine, Università Campus Bio-Medico di Roma, 00128 Rome, ItalySchool of Medicine, Università Campus Bio-Medico di Roma, 00128 Rome, ItalyDepartment of Otorhinolaryngology, Clinica Universidad de Navarra, 31008 Pamplona, SpainTransfusion Medicine and Cell Therapy, Fondazione Policlinico Università Campus Bio-Medico di Roma, 00128 Rome, ItalyIntegrated Therapies in Otolaryngology, Fondazione Policlinico Università Campus Bio-Medico di Roma, 00128 Rome, ItalyBackground: With promising outcomes, platelet-rich plasma (PRP) has recently been suggested as a treatment for olfactory dysfunction (OD). Methods: Clinical studies utilizing PRP in OD caused by COVID-19, trauma, anesthetic exposure, viral infection, and chronic rhinosinusitis were included in a systematic review. Results: Ten clinical studies were qualitatively analyzed. Six of these studies used the PRP for OD caused by COVID-19, one on OD after functional endoscopic sinus surgery, and three on post-infectious or post-trauma OD. The population included 531 patients, ranging in age from 15 to 63. Conclusion: The use of PRP may be a risk-free and efficient therapeutic option with very encouraging outcomes. Indeed, it enhances olfactory perception in patients who not only exhibit COVID-19 infection aftereffects, but also in those who have lost their sense of smell due to trauma, rhinosinusitis, rhinitis, or even surgery. To evaluate the PRP’s therapeutic benefits in OD patients and to compare the efficacy of different therapeutic protocols with regard to treatment schedules, there is an urgent need for focused controlled trials.https://www.mdpi.com/2077-0383/13/3/782olfactory dysfunctionplatelet-rich plasmasmell lossanosmiaCOVID-19
spellingShingle Antonio Moffa
Domiziana Nardelli
Lucrezia Giorgi
Simone Di Giovanni
Luca Carnuccio
Carmen Mangino
Peter Baptista
Michele Vacca
Manuele Casale
Platelet-Rich Plasma for Patients with Olfactory Dysfunction: Myth or Reality? A Systematic Review
Journal of Clinical Medicine
olfactory dysfunction
platelet-rich plasma
smell loss
anosmia
COVID-19
title Platelet-Rich Plasma for Patients with Olfactory Dysfunction: Myth or Reality? A Systematic Review
title_full Platelet-Rich Plasma for Patients with Olfactory Dysfunction: Myth or Reality? A Systematic Review
title_fullStr Platelet-Rich Plasma for Patients with Olfactory Dysfunction: Myth or Reality? A Systematic Review
title_full_unstemmed Platelet-Rich Plasma for Patients with Olfactory Dysfunction: Myth or Reality? A Systematic Review
title_short Platelet-Rich Plasma for Patients with Olfactory Dysfunction: Myth or Reality? A Systematic Review
title_sort platelet rich plasma for patients with olfactory dysfunction myth or reality a systematic review
topic olfactory dysfunction
platelet-rich plasma
smell loss
anosmia
COVID-19
url https://www.mdpi.com/2077-0383/13/3/782
work_keys_str_mv AT antoniomoffa plateletrichplasmaforpatientswitholfactorydysfunctionmythorrealityasystematicreview
AT domiziananardelli plateletrichplasmaforpatientswitholfactorydysfunctionmythorrealityasystematicreview
AT lucreziagiorgi plateletrichplasmaforpatientswitholfactorydysfunctionmythorrealityasystematicreview
AT simonedigiovanni plateletrichplasmaforpatientswitholfactorydysfunctionmythorrealityasystematicreview
AT lucacarnuccio plateletrichplasmaforpatientswitholfactorydysfunctionmythorrealityasystematicreview
AT carmenmangino plateletrichplasmaforpatientswitholfactorydysfunctionmythorrealityasystematicreview
AT peterbaptista plateletrichplasmaforpatientswitholfactorydysfunctionmythorrealityasystematicreview
AT michelevacca plateletrichplasmaforpatientswitholfactorydysfunctionmythorrealityasystematicreview
AT manuelecasale plateletrichplasmaforpatientswitholfactorydysfunctionmythorrealityasystematicreview